期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

高血压伴双下肢反复浮肿1例

One case of hypertension complicated by repeated edema of both lower limbs
原文传递
导出
摘要 患者,女,57岁。因“反复头昏头痛伴双下肢浮肿5年余”于2022年10月25就诊于首钢水钢医院门诊。患者慢性起病,病情反复。
作者 张敏 解美灵 刘梅花 王声飞 喻群群 Zhang Min;Xie Meiling;Liu Meihua;Wang Shengfei;Yu Qunqun(Department of Cardiology,Shougang Shuigang Hospital,Liupanshui 553000,Guizhou Province,China;Department of Nursing,Shougang Shuigang Hospital,Liupanshui 553000,Guizhou Province,China)
机构地区 首钢水钢医院心内科 首钢水钢医院护理部
出处 《中国基层医药》 CAS 2023年第8期1248-1250,共3页 Chinese Journal of Primary Medicine and Pharmacy
关键词 双下肢浮肿 慢性起病 高血压 病情反复 水钢医院 头昏
分类号 R544.1 [医药卫生—心血管疾病]
  • 相关文献

参考文献3

二级参考文献62

  • 1卫生部心血管病防治研究中心.中国心血管病报告2006.北京:中国大百科全书出版社,2007.
  • 2Liu L, Zhang Y, Liu G, et al. FEVER Study Group. The Felodipine Event Reduction (FEVER) Study: a randomized long- term placebo-controlled trial in Chinese hypertensive patients. J Hypertens, 2005,23 : 2157-2572.
  • 3Julius S, Kjeldsen SE, Weber M, et al. VALUE trial group. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet, 2004,363:2022-2031.
  • 4Sever PS, Dahlof B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet ,2003,361 : 1149-1158.
  • 5Weber MA, Bakris GL, Dahlof B, et al. Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular risk. Blood Press ,2007,16 : 13-19.
  • 6Wang JG, Li Y, Franklin SS, et al. Prevention of stroke and myocardial infarction by amlodipine and Angiotensin receptor blockers : a quantitative overview. Hypertension, 2007,50 : 181 - 188.
  • 7Makino H, Haneda M, Babazono T, et al. Microalbuminuria reduction with telmisartan in normotensive and hypertensive Japanese patients with type 2 diabetes : a post-hoc analysis of The Incipient to Overt: Angiotensin Ⅱ Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) study. Hypertens Res,2008,31:657-664.
  • 8Sharma A, Bagchi A, Kinagi SB, et al. Results of a comparative, phase Ⅲ, 12-week, muhicenter, prospective, randomized, double-blind assessment of the efficacy and tolerability of a fixed- dose combination of telmisartan and amlodipine versus amlodipine monotherapy in Indian adults with stage Ⅱ hypertension. Clin Ther, 2007,29 : 2667 -2676.
  • 9Chrysant SG. Amlodipine/ARB fixed-dose combinations for the treatment of hypertension : focus on amlodipine/olmesartan combination. Drugs Today (Barc) ,2008,44:443-453.
  • 10Ichihara A, Kaneshiro Y, Sakoda M, et al. Add-on amlodipine improves arterial function and structure in hypertensive patients treated with an angiotensin receptor blocker. J Cardiovasc Pharmacol,2007,49 : 161-166.

共引文献236

中国基层医药
2023年 第8期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部